Clinical Trial Update: Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Imiquimod 3.75% cream with Zyclara 3.75% cream for actinic keratosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Imiquimod 3.75% Cream (Imiquimod)
• Zyclara 3.75% cream (Imiquimod)

Snippet

Sponsor: Teva Pharmaceuticals USA | Conditions: Actinic Keratosis | Phase 3 | Status: COMPLETED | Results posted: 2020-10-30